Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Immune Control of Tuberculosis by IFN-γ-Inducible LRG-47
2003 StandoutScience
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.
1994
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
2017
Differential Membrane Localization of ERas and Rheb, Two Ras-related Proteins Involved in the Phosphatidylinositol 3-Kinase/mTOR Pathway
2005 StandoutNobel
EGFR Antagonists in Cancer Treatment
2008 Standout
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype.
1992
NCAM and lung cancer
1994
Mutational activation of the K-ras oncogene and the effect of chemotherapy in advanced adenocarcinoma of the lung: a prospective study.
1997
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
2013 StandoutNature
Atypical Adenomatous Hyperplasia of the Lung: A Probable Forerunner in the Development of Adenocarcinoma of the Lung
2001
K-rasOncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
1990
Role of ERas in promoting tumour-like properties in mouse embryonic stem cells
2003 StandoutNatureNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Stability of K-ras mutations throughout the natural history of human colorectal cancer
1992
The development and progression of adenocarcinoma of the lung
1994
The biology and management of non-small cell lung cancer
2018 StandoutNature
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Lung Cancer
2008 Standout
HIF2α cooperates with RAS to promote lung tumorigenesis in mice
2009 StandoutNobel
A genetic model for colorectal tumorigenesis
1990 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
K‐ras mutations in human adenocarcinoma of the lung: Association with smoking and occupational exposure to asbestos
1993
The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2004
The Hallmarks of Cancer
2000 Standout
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
2005 StandoutNature
Tumor suppressor genes
1991 Standout
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
The neural cell adhesion molecule NCAM in multiple myeloma
1996
Expression of neural cell adhesion molecules (polysialylated form of neural cell adhesion molecule and L1‐cell adhesion molecule) on resected small cell lung cancer specimens: In relation to proliferation state
2001
WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis
2009
Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer
2005 Standout
Suppression of lung adenocarcinoma progression by Nkx2-1
2011 Nature
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Wnt/β-Catenin Signaling and Disease
2012 Standout
The p53 tumour suppressor gene
1991 StandoutNature
Increased expression of mutant forms of p53 oncogene in primary lung cancer
1990
Targeting RAS signalling pathways in cancer therapy
2003 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Expression of highly polysialylated neural cell adhesion molecule in pancreatic cancer neural invasive lesion
1999
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
1994 StandoutNature
KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
2005
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
Estrogen Resistance Caused by a Mutation in the Estrogen-Receptor Gene in a Man
1994 Standout
MicroRNA signatures in human cancers
2006 Standout
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
2001
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Metabolic selection of glycosylation defects in human cells
2001 StandoutNobel
Differential Effects of Unnatural Sialic Acids on the Polysialylation of the Neural Cell Adhesion Molecule and Neuronal Behavior
2002 StandoutNobel
Pten controls lung morphogenesis, bronchioalveolar stem cells, and onset of lung adenocarcinomas in mice
2007 StandoutNobel
Second Lung Cancers in Patients After Treatment for an Initial Lung Cancer
1998
Glycosylation in cancer: mechanisms and clinical implications
2015 Standout
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
Molecular Basis for G Protein Control of the Prokaryotic ATP Sulfurylase
2006 StandoutNobel
Analysis of oncogene alterations in human endometrial carcinoma: Prevalence of ras mutations
1991
Detection of trisomy 7 in nonmalignant bronchial epithelium from lung cancer patients and individuals at risk for lung cancer.
1996
p53 Mutations in Human Cancers
1991 StandoutScience
Small GTP-Binding Proteins
2001 Standout
Polysialic Acid, a Glycan with Highly Restricted Expression, Is Found on Human and Murine Leukocytes and Modulates Immune Responses
2008 StandoutNobel
Phenotypic characterization of human colorectal cancer stem cells
2007 Standout
Adenocarcinoma of the lung: its development and malignant progression
1993
Deficiencies in Mouse Myh and Ogg1 Result in Tumor Predisposition and G to T Mutations in Codon 12 of the K-Ras Oncogene in Lung Tumors
2004 StandoutNobel
Molecular Determinants of Regulated Exocytosis
2002 StandoutNobel
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 StandoutScience
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Small adenocarcinoma of the lung. Histologic characteristics and prognosis
1995 Standout
Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.
1992
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
1991
p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines.
1991
BRAF and RAS mutations in human lung cancer and melanoma.
2002
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
1990 StandoutScience
Prognostic significance of polysialic acid expression in resected non-small cell lung cancer.
2001
The Differential Effects of Mutant p53 Alleles on Advanced Murine Lung Cancer
2005
Works of Peter C. Van Bodegom being referenced
Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
1991
Second primary lung cancer: importance of long term follow up.
1989
Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.
1988